Shares of Campbell Soup Company (NYSE: CPB) stayed in green territory on Thursday. The stock has gained 9% year-to-date and 14% over the past three months. The company delivered encouraging results for its third quarter of 2022 a day ago, with both revenue and earnings beating estimates, and raised its sales guidance for the full year. Here are three factors that work in favor of the soups and snacks maker:
Campbell generated net sales of $2.1 billion in Q3, which reflected year-over-year growth of 7% on a reported basis and 9% on an organic basis, and surpassed expectations. The top line growth was driven by sustained demand for its brands as well as improved supply and inflation-driven pricing. Adjusted EPS rose 37% YoY to $0.70 and exceeded projections.
Campbell witnessed strong demand for its products during the quarter with consumption rising 4% YoY. Organic net sales in the Meals & Beverages division increased 9% in Q3. The rising inflation levels appear to be supporting at-home food consumption trends. In-market soup consumption continued to grow, rising 5% YoY.
Despite a low to mid double-digit increase in average prices, Campbell witnessed volume growth in its soup and Italian sauce categories, meaning customers are still buying them regardless of the price increases. Consumption of Prego increased 7% YoY in Q3.
Campbell is rolling out a pipeline of new products that cater to consumers’ needs of cooking quick meals at home and seeking new specialty flavors to enhance their meals. The company will launch its Pacific ready-to-serve soups and chilis in the fourth quarter of this year.
The Snacks division saw organic net sales growth of 8% in the third quarter. In-market consumption grew 6% helped by strong performances from its power brands. The company’s largest snacks brand Goldfish saw consumption grow 8% in Q3 and strategies to broaden its consumer base are paying off.
Campbell expects to see strong demand for its brand portfolio along with supply recovery in the coming months. Based on this expectation, the company raised its sales guidance for the full year of 2022. Net sales growth is expected to be flat to up 1% while organic net sales growth is expected to be 1-2%. The company expects to face continued margin pressure from inflation through the year and is guiding for adjusted EPS of $2.75-2.85.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
AutoZone, Inc. (NYSE: AZO) is a much sought-after automotive parts retailer among do-it-yourself customers, especially after the virus-related movement restrictions forced people to stay indoors. The company’s stock has remained
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products, designed for minimally invasive surgery, help healthcare professionals conduct procedures
Drugstore chain Walgreens Boots Alliance, Inc. (NASDAQ: WBA) witnessed a spike in customer traffic in the last couple of years due to the vaccination drive and the high demand for